Nexalin Technology NXL
NASDAQ NXL
$7.53 +3.25 (+75.93%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nexalin Technology (NXL) EBIT Margin (2021 - 2026)

Updated

Nexalin Technology's EBIT Margin was -18479.69% in Q2 2026, down 16183.47 percentage points from -2296.22% a year earlier and down 4299.74 percentage points from the prior quarter.

Analysis

Nexalin Technology (NXL) EBIT Margin (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Nexalin Technology's EBIT Margin was -4202.54% through Jun 30, 2026, up 954.97 percentage points year-over-year; for FY2025, it came in at -2781.69%, up 1814.45 percentage points from FY2024.

  • EBIT Margin shows a four-year change of +1396.01 percentage points (FY2021 to FY2025).
  • In earlier years, EBIT Margin was -4596.14% in FY2024 (+547.34 pp), -5143.48% in FY2023 (-5004.75 pp), -138.72% in FY2022 (+4038.97 pp) and -4177.70% in FY2021.
  • The Q2 2026 figure marks the lowest quarterly EBIT Margin in data going back to Q3 2021.
  • Compared with a year earlier, EBIT Margin was higher in three of the last eight quarters, with an average year-over-year change of -2857.83 percentage points.
  • The best year-over-year quarter for EBIT Margin over five years was Q4 2025 (a gain of 9175.62 percentage points); the worst was Q2 2026 (a drop of 16183.47 percentage points).
  • Per Business Quant data, NXL's EBIT Margin in the three quarters before Q2 2026 was -14179.95% (Q1 2026), -1403.86% (Q4 2025) and -12924.30% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 13.44%
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 33.60%
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 18.08%
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 25.18%
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 13.31%
10 Nexalin Technology 3.09 Mn -8.70 Mn 8,897.00 -18,479.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -18,479.69%
Mar 31, 2026 -14,179.95%
Dec 31, 2025 -1,403.86%
Sep 30, 2025 -12,924.30%
Jun 30, 2025 -2,296.22%
Mar 31, 2025 -4,903.63%
Dec 31, 2024 -10,579.48%
Sep 30, 2024 -6,962.11%
Jun 30, 2024 -4,832.42%
Mar 31, 2024 -1,364.81%
Dec 31, 2023 -7,910.37%
Sep 30, 2023 -10,017.57%
Jun 30, 2023 -2,467.25%
Mar 31, 2023 -2,550.48%
Dec 31, 2022 -1,872.83%
Sep 30, 2022 -53.77%
Jun 30, 2022 -107.44%
Mar 31, 2022 -116.02%
Dec 31, 2021 -2,406.30%
Sep 30, 2021 -3,207.88%
API Access

Nexalin Technology EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NXL&period=max&api_key=YOUR_API_KEY